DLP stands for Data Lock Point. In the context of pharmacovigilance and regulatory reporting, a Data Lock Point is a specific date designated as the cut-off date for including data in various safety and benefit-risk evaluation reports. The data lock point is crucial as it ensures that the reports contain the most up-to-date and relevant safety and efficacy information related to a pharmaceutical product.
Overall, the Data Lock Point is a significant milestone in the reporting and monitoring of the safety and efficacy of pharmaceutical products. By adhering to the designated cut-off date, regulatory authorities can assess the most current safety profile of a product, ensure patient safety, and make informed decisions regarding its continued use in the market. Pharmaceutical companies must closely follow the regulatory guidelines and timelines to meet the data lock points and submit complete and accurate reports as part of their pharmacovigilance responsibilities.
Signal Management Process
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management